Facebook-f Twitter Instagram Podcast Youtube Tiktok Linkedin-in Pinterest Envelope Share
MASH Rec CARD (13)
CLICK HERE TO SHARE YOUR STORY!
  • About
    • Meet Our Contributors
    • Meet Our Partners
    • Meet the Patient Worthy Team
    • Collaborative Content On Patient Worthy
  • Diseases
  • Share Your Story
    • Patient Worthy Content Submission Guidelines
    • Patient Worthy Writing Prompts
    • Submit Your Story
    • Patient Stories
  • Resources
    • Library
    • Events
    • Patient Worthy FAQs
  • Podcast
  • Contact
Menu
  • About
    • Meet Our Contributors
    • Meet Our Partners
    • Meet the Patient Worthy Team
    • Collaborative Content On Patient Worthy
  • Diseases
  • Share Your Story
    • Patient Worthy Content Submission Guidelines
    • Patient Worthy Writing Prompts
    • Submit Your Story
    • Patient Stories
  • Resources
    • Library
    • Events
    • Patient Worthy FAQs
  • Podcast
  • Contact
  • Join PW

Daily Archives: October 1, 2021

  1. Home>
  2. 2021>
  3. October>
  4. 1
LIVMARLI Becomes First FDA-Approved Drug for Alagille Syndrome Pruritus
rawpixel / Pixabay

LIVMARLI Becomes First FDA-Approved Drug for Alagille Syndrome Pruritus

  • Post author:Jessica Lynn
  • Post published:October 1, 2021
  • Post category:Alagille Syndrome

In the past, there have not been any available treatments to tackle cholestatic pruritus, or a severe and unrelenting itch, for patients with liver diseases such as Alagille syndrome. However,…

Continue Reading LIVMARLI Becomes First FDA-Approved Drug for Alagille Syndrome Pruritus
The Network of Tyrosinemia Celebrates 4th Annual NOTA Experience Family Conference

The Network of Tyrosinemia Celebrates 4th Annual NOTA Experience Family Conference

  • Post author:Trudy Horsting
  • Post published:October 1, 2021
  • Post category:Tyrosinemia

NOTA, The Network of Tyrosinemia Advocates, held their 4th Annual NOTA Experience, a family conference in September, despite the extraordinary constraints of time, a pandemic, transportation challenges, and the special…

Continue Reading The Network of Tyrosinemia Celebrates 4th Annual NOTA Experience Family Conference
First Patient Joins AMO-02 Trial for Congenital DM1
source: pixabay.com

First Patient Joins AMO-02 Trial for Congenital DM1

  • Post author:Jessica Lynn
  • Post published:October 1, 2021
  • Post category:Myotonic Dystrophy

Clinical trials are important to understanding both more about certain conditions and more about the safety, efficacy, and tolerability of drugs designed to treat these conditions. Currently, biopharmaceutical company AMO…

Continue Reading First Patient Joins AMO-02 Trial for Congenital DM1
Fundraising for Diego: Help to Support a DMD Patient

Fundraising for Diego: Help to Support a DMD Patient

  • Post author:Kendall Mason
  • Post published:October 1, 2021
  • Post category:Duchenne Muscular Dystrophy

It's a beautiful thing when a community pulls together to support one of its members. This is exactly what the Madeira community is doing for 16-year-old Diego Ramirez. He recently…

Continue Reading Fundraising for Diego: Help to Support a DMD Patient
This Community Came Together to Support a Boy with ARPKD

This Community Came Together to Support a Boy with ARPKD

  • Post author:Kendall Mason
  • Post published:October 1, 2021
  • Post category:Autosomal recessive polycystic kidney disease

Lytle, Texas is a small town located outside of San Antonio. Recently, the entire community came together to support a young boy living with autosomal recessive polycystic kidney disease (ARPKD).…

Continue Reading This Community Came Together to Support a Boy with ARPKD
Rare Classroom: Wolff-Parkinson-White Syndrome
source: shutterstock

Rare Classroom: Wolff-Parkinson-White Syndrome

  • Post author:James Moore
  • Post published:October 1, 2021
  • Post category:Wolff-Parkinson-White syndrome

Welcome to the Rare Classroom, a new series from Patient Worthy. Rare Classroom is designed for the curious reader who wants to get informed on some of the rarest, most…

Continue Reading Rare Classroom: Wolff-Parkinson-White Syndrome
MarzAA Earns Orphan Drug Designation for Factor VII Deficiency
source: pixabay.com

MarzAA Earns Orphan Drug Designation for Factor VII Deficiency

  • Post author:Jessica Lynn
  • Post published:October 1, 2021
  • Post category:Factor VII deficiency

The FDA created its Orphan Drug Act to incentivize drug developers to develop solutions for patients with rare or life-threatening conditions. Now, Orphan Drug designation is granted to drugs or…

Continue Reading MarzAA Earns Orphan Drug Designation for Factor VII Deficiency
Finding Light Through Story-The Power of Ambassadorship in the Endometrial Cancer Community
*cancer that cannot be removed with surgery or has spread to other parts of the body. GEJ= gastroesophageal junction (where the esophagus joins the stomach)
CLICK HERE TO SHARE YOUR STORY!
We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.
Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Partner With Us
Submit a Story

Keep Up to Date

Subscribe to Our Newsletter
Check Out Rare Events
Get Inspired By Our Memes

Learn More

About Us
Rare Diseases and Conditions
Terms of Use
Privacy Notice
Privacy Policy for CA Residents
EU/UK Privacy Notice
Data Privacy Framework: Consumer Privacy Policy
Consumer Health Data Privacy Policy
Cookie Notice

Facebook-f Twitter Instagram Podcast Youtube Tiktok Linkedin-in Pinterest Envelope

© Copyright 2024 Patient Worthy

Sign Up With a Patient Worthy Account and Share Your Rare Story

- OR -

Sign Up For Our Patient Panel

Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.

More Info

We're Happy You're Here!

What best describes you when it comes to rare disease? (check all that apply)

What rare disease(s)/conditions are most important to you?

Visit Home Page or

Thank you for signing up for a Patient Worthy Account!

Have a rare disease story to share? Let us know

Share Story

- OR -

Sign Up For Our Patient Panel

Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.

More Info